Levobupivacaine is a local anesthetic used to numb specific areas of the body during surgery, dental procedures, or pain management treatments so patients don't feel pain in that region.[2] Chirocaine is currently approved and in use across 23 indications[4].[1]
Chirocaine is one of 269 small molecule programs targeting Femoral Neck Fracture. It is currently in Approved.
Indications
Total Trials
Active Trials
Competitors
FDA Application
NDA/BLA/ANDA regulatory filings
Pipeline
Competition
143 competitors in Osteoarthritis
Chirocaine
Toradol
Cataflam
Bayer Aspirin
Enbrel
Glucophage
Precedex
Protonix
Catapres
MS Contin
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Timeline
Clinical
Regulatory
Aug 5, 1999
CHIROCAINE
NDA NDA020997
Sources
Details